Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$3.41 - $8.95 $20,787 - $54,559
-6,096 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$7.78 - $15.31 $47,426 - $93,329
6,096 New
6,096 $50,000
Q4 2020

Feb 12, 2021

SELL
$10.16 - $23.98 $56,123 - $132,465
-5,524 Closed
0 $0
Q3 2020

Nov 04, 2020

BUY
$7.44 - $13.15 $41,098 - $72,640
5,524 New
5,524 $56,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $96.5M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.